'MabThera Confirmed As Beneficial For Treating Non-Hodgkin's Lymphoma'Medical News TodayThe European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded, after conducting a quality review of the geneti…
In-PharmaTechnologist.comEMA confirms Roche's MabThera made at Vacaville site poses no health riskThe Pharma LetterThe review of MabThera was initiated after the unexpected detection of Leptospira licerasiae at an early stage (pre-harvest) of the m…
Combo Tx Better in HIV-Related LymphomaMedPage TodayAdding the monoclonal antibody rituximab (Rituxan) to chemotherapy improves outcomes for HIV patients diagnosed with non-Hodgkin's lymphoma. Note that, on the other hand, patients with HIV-associa…
Clinical Oncology NewsClinical ConundrumsClinical Oncology NewsTrue or False: The preliminary results of the open-label Phase II GAUSS trial of rituximab (Rituxan; Biogen Idec, Genentech) versus obinutuzumab (GA101, Roche) for relapsed follicular lymph…
AbD Serotec plans to launch series of novel anti-drug antibodiespharmabiz.comStarting with the recent launch of fully human, recombinant antibodies binding Rituximab (Rituxan) and Trastuzumab (Herceptin), AbD Serotec plans to expand this product catego…
Panel of HuCAL Anti-Drug Antibodies to be launched by AbD SerotecNews-Medical.netStarting with the recent launch of fully human, recombinant antibodies binding Rituximab (Rituxan ® ) and Trastuzumab (Herceptin ® ), AbD Serotec plans to expand this pr…
MorphoSys' Unit To Intorduce Series Of Novel Anti-drug Antibodies – Quick FactsRTT NewsStarting with the recent launch of fully human, recombinant antibodies binding Rituximab and Trastuzumab, AbD Serotec intends to expand this product category wit…
Spectrum Pharma Begins Phase 2 Study Of ZEVALIN Injection – Quick FactsRTT News(RTTNews) – Spectrum Pharmaceuticals (SPPI: News ) announced the initiation of a Phase 2 study evaluating ZEVALIN Injection for intravenous use + rituximab in combination wi…
Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN(R) in Combination …MarketWatch (press release)The trial is designed to enroll a total of 100 patients in North America, who will be randomized to one of two treatment arms: ZEVALIN + rituxim…
MorphoSys to Present MOR208 Preclinical Combination Therapy Data at ASCO MeetingReutersSynergistic Effects Seen with Four Approved Treatment Options Including Rituximab and Ofatumumab MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announ…